Dachaigh › Luchd-obrach › Biomea Fusion, Inc.
Biomea Fusion, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Biomea Fusion, Inc. 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $124,904.
A bheil Biomea Fusion, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Biomea Fusion, Inc. 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 28 Dàmh 2024. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Biology Scientist | 1 | $118,976 |
| Research Associate | 1 | $86,424 |
| Sr. Manager, Investor Relations & Corporate Development | 1 | $124,904 |
| Senior Manager, Regulator Affairs | 1 | $160,000 |
| Lead Clinical Data Manager | 1 | $153,088 |
| Vice President, Drug Safety & Pharmacovigilance | 1 | $325,782 |
| Senior Research Associate | 1 | $93,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $118,976 |
| FY2025 | 4 | $156,544 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists2
- Bioengineers and Biomedical Engineers1
- Public Relations Managers1
- Regulatory Affairs Managers1
- Data Scientists1
- Natural Sciences Managers1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Research Associate | $93,000–$110,000 Ìre I | San Carlos, CA | 28 Dàmh 2024 | 30 Dàmh 2024 | Dearbhaichte, an uair sin air a tharraing air ais |
| Vice President, Drug Safety & Pharmacovigilance | $325,782–$375,000 Ìre IV | 4th Floor, CA | 24 Iuch 2024 | 20 Faoi 2025 | Dearbhaichte, an uair sin air a tharraing air ais |
| Lead Clinical Data Manager | $153,088–$160,000 Ìre III | Redwood City, CA | 29 Ògmh 2023 | 7 Iuch 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Senior Manager, Regulator Affairs | $160,000–$175,000 Ìre II | Redwood City, CA | 22 Cèit 2023 | 30 Cèit 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Research Associate | $86,424–$100,000 Ìre II | San Carlos, CA | 13 Gearr 2023 | 15 Lùna 2023 | Dearbhaichte |
| Biology Scientist | $118,976–$135,000 Ìre III | San Carlos, CA | 13 Gearr 2023 | 15 Lùna 2023 | Dearbhaichte |
| Sr. Manager, Investor Relations & Corporate Development | $124,904–$160,000 Ìre II | Redwood City, CA | 27 Faoi 2023 | 10 Gearr 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).